Status:

COMPLETED

Effect of Red Clover on Menopause Symptoms and Lipid Profile

Lead Sponsor:

Medipol University

Conditions:

Menopause

Eligibility:

FEMALE

45-55 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to investigate the effects of red clover isoflavones on menopausal symptoms and lipid profile in menopausal females.This prospective randomized, double-blind, placeb...

Detailed Description

The goal of this clinical trial is to investigate the effects of red clover isoflavones on menopausal symptoms and lipid profile in menopausal females. This was a prospective, randomized, double-blind...

Eligibility Criteria

Inclusion

  • History of amenorrhea for at least 12 months
  • Being aged 45-55
  • Having received a diagnosis of dyslipidemia (at the present admission or within the past 3 months)
  • Not receiving treatment for dyslipidemia
  • Absence of other chronic diseases
  • Follicle stimulating hormone level of \>40 pg/mL
  • Body mass index (BMI) of \<30 kg/m2

Exclusion

  • Currently or previously undergoing hormone replacement therapy (either in the past, immediately before, or during the study)
  • Using any phytotherapeutic drug
  • Diagnosed with diabetes
  • Presence of anemia
  • Presence of cardiovascular disease Presence of musculoskeletal disease
  • Presence of asthma / chronic obstructive pulmonary disease
  • Presence of malignancy
  • Prsence of genital or gynecological disease (excluding menopausal symptoms)
  • Presence of neurological or psychiatric disease
  • Conditions involving acute or chronic inflammation
  • Experiencing acute or chronic infection
  • Displaying abnormal liver, kidney, or thyroid function tests
  • Engaging in smoking, alcohol consumption, or drug use
  • Suffering from sexual dysfunction (except for menopause-related reasons)
  • Unable to complete the study, or not attending 3-month or 6-month follow-up

Key Trial Info

Start Date :

March 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 20 2023

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT06209697

Start Date

March 20 2022

End Date

September 20 2023

Last Update

January 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Istanbul Medipol University

Istanbul, Pendik /Istanbul, Turkey (Türkiye), 34893